Tempus Pixel vs iPredict Eye Screening
AI Verdict
Choose Tempus Pixel if…
Choose Tempus Pixel if your institution requires an advanced, multi-modality AI platform for in-depth medical imaging analysis across cardiology, oncology, and neurology. This tool is ideal for radiologists and specialists seeking to enhance diagnostic accuracy, leverage 3D visualization, and streamline complex image interpretation workflows with automated reporting and real-time collaboration.
View Tempus Pixel →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if your primary care clinic or telemedicine service needs a fast, easy-to-operate AI solution for early detection of common eye diseases like AMD, DR, and Glaucoma. This platform is best suited for broad patient screening, particularly for those aged 50 and older, and offers the added benefit of predicting systemic disease risks like stroke and heart attack, integrating seamlessly into routine check-ups.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus Pixel | iPredict Eye Screening |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iPredict Eye ScreeningTool B emphasizes ease of operation, a non-invasive approach, an advanced touchscreen interface, and rapid results (under 5 minutes for the test, under 60 seconds for the report), making it highly user-friendly for a broader range of clinical staff, particularly in primary care settings. Tool A, while offering advanced features, appears more tailored to specialized radiological workflows.
Clinical Value
iPredict Eye ScreeningBoth tools are FDA-cleared and offer significant clinical benefits. However, Tool B provides explicit high accuracy percentages for its screening capabilities (approx. 95% average, AMD sensitivity 86.86%, specificity 94.13%) and uniquely extends its value by offering risk prediction for systemic diseases like stroke and heart attack alongside eye screening. This broader preventative scope and quantifiable accuracy give it an edge.
Pricing & Value
iPredict Eye ScreeningTool B offers greater transparency in its pricing model, detailing a per-patient screening on a SaaS model with an estimated cost of $10-$20 per patient, linked to Medicare/commercial payor reimbursement. This provides potential customers with a clearer understanding of the financial investment and potential ROI compared to Tool A's 'contact for quote' approach.
Enterprise Readiness
Tempus PixelBoth tools are FDA-cleared, HIPAA compliant, and cloud-based, indicating strong foundational readiness. However, Tool A explicitly lists integration with existing PACS, EHR, and RIS environments, which are comprehensive enterprise systems for radiology and broader hospital workflows. Additionally, Tempus, as the parent company, is a larger and more established entity in healthcare AI, suggesting more robust enterprise support and infrastructure.
Innovation
iPredict Eye ScreeningWhile both leverage AI, Tool B demonstrates a higher degree of innovation by combining multi-disease retinal screening with a unique online health risk prediction system for systemic conditions such as stroke and heart attack. This integrated approach to preventative health and broader risk assessment extends beyond traditional diagnostic enhancement.
Support & Docs
Tempus PixelTempus (Tool A) provides more comprehensive support resources, including multiple contact channels via email and phone, and a publicly accessible 'Document Library' with various guides and system requirements for Tempus Pixel. While iHealthScreen (Tool B) offers contact information and mentions training, the breadth of documented resources appears less extensive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus Pixel | iPredict Eye Screening |
|---|---|---|
| Name | Tempus Pixel | iPredict Eye Screening |
| Company | Tempus (formerly Arterys) | iHealthScreen |
| Tagline | The future of precision medicine that only human + AI can achieve. | AI-powered screening tools for early detection of retinal and systemic diseases. |
| Primary AI Categories | Cardiology AI | Cardiology AI, Neurology AI, Ophthalmology AI |
| Key Features (General) | AI-powered analysis, Cloud-based platform, Real-time collaboration, Multi-modality support (MRI, CT, X-ray, ultrasound), Automated reporting, 3D visualization, Quantitative analysis, DICOM compatibility. | AI-Based Screening, Electronic Health Record (EHR) Solutions, AI-Based Telemedicine Service, Image Analyzer, Online Health Risk Prediction System, Fast results, High accuracy, Easy to operate, non-invasive, with an advanced touchscreen interface. |
| Specific Disease Screening/Analysis | Enhances diagnostic accuracy and workflow efficiency for radiologists and clinicians across cardiology, oncology, and neurology. | AI-powered screening tool for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma. Also provides risk prediction for systemic diseases like stroke and heart attack. |
Videos
Demos, reviews, and walkthroughs featuring Tempus Pixel and iPredict Eye Screening.